These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
318 related items for PubMed ID: 23412396
1. Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects. Kinsey SG, Wise LE, Ramesh D, Abdullah R, Selley DE, Cravatt BF, Lichtman AH. J Pharmacol Exp Ther; 2013 Jun; 345(3):492-501. PubMed ID: 23412396 [Abstract] [Full Text] [Related]
8. Lack of hippocampal CB1 receptor desensitization by Δ(9)-tetrahydrocannabinol in aged mice and by low doses of JZL 184. Feliszek M, Bindila L, Lutz B, Zimmer A, Bilkei-Gorzo A, Schlicker E. Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):603-12. PubMed ID: 26984820 [Abstract] [Full Text] [Related]
16. Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain. Guindon J, Guijarro A, Piomelli D, Hohmann AG. Br J Pharmacol; 2011 Aug; 163(7):1464-78. PubMed ID: 21198549 [Abstract] [Full Text] [Related]
17. Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances retrograde endocannabinoid signaling. Pan B, Wang W, Long JZ, Sun D, Hillard CJ, Cravatt BF, Liu QS. J Pharmacol Exp Ther; 2009 Nov; 331(2):591-7. PubMed ID: 19666749 [Abstract] [Full Text] [Related]
18. Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats. Sciolino NR, Zhou W, Hohmann AG. Pharmacol Res; 2011 Sep; 64(3):226-34. PubMed ID: 21600985 [Abstract] [Full Text] [Related]
19. Combined inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice. Crowe MS, Leishman E, Banks ML, Gujjar R, Mahadevan A, Bradshaw HB, Kinsey SG. Br J Pharmacol; 2015 Apr; 172(7):1700-12. PubMed ID: 25393148 [Abstract] [Full Text] [Related]